natur histori multipl sclerosi studi applic plan interpret clinic therapeut trial hypothet entri criteria typic clinic therapeut trial patient elig clinic-bas studi multipl sclerosi MS london ontario patient observ frequenc deterior point disabl statu scale dss kurtzk feasibl endpoint clinic trial number patient random clinic trial signific result alpha power observ rate deterior linear dss frequenc progress stay time level dss frequenc progress time level disabl consider intrapati interpati variat time data major implic design conduct clinic therapeut trial MS 